142 related articles for article (PubMed ID: 7296791)
1. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
Keren A; Tzivoni D; Gavish D; Levi J; Gottlieb S; Benhorin J; Stern S
Circulation; 1981 Dec; 64(6):1167-74. PubMed ID: 7296791
[TBL] [Abstract][Full Text] [Related]
2. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
4. Ventricular pacing in atypical ventricular tachycardia.
Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
[TBL] [Abstract][Full Text] [Related]
6. Disopyramide-induced Torsade de Pointes.
Tzivoni D; Keren A; Stern S; Gottlieb S
Arch Intern Med; 1981 Jun; 141(7):946-7. PubMed ID: 7235820
[TBL] [Abstract][Full Text] [Related]
7. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
8. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
9. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.
Kay GN; Plumb VJ; Arciniegas JG; Henthorn RW; Waldo AL
J Am Coll Cardiol; 1983 Nov; 2(5):806-17. PubMed ID: 6630761
[TBL] [Abstract][Full Text] [Related]
10. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
Wald RW; Waxman MB; Colman JM
J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
Roden DM; Woosley RL; Primm RK
Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
[TBL] [Abstract][Full Text] [Related]
12. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
[TBL] [Abstract][Full Text] [Related]
13. Polymorphous ventricular tachycardia associated with acute myocardial infarction.
Wolfe CL; Nibley C; Bhandari A; Chatterjee K; Scheinman M
Circulation; 1991 Oct; 84(4):1543-51. PubMed ID: 1914096
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
15. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
16. Torsade de pointes. A cause of syncope with atrioventricular block.
Steinbrecher UP; Fitchett DH
Arch Intern Med; 1980 Sep; 140(9):1223-6. PubMed ID: 7406620
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamics in ventricular arrhythmias and in their treatment].
Lüderitz B; Manz M
Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced torsade de pointes. Incidence, management and prevention.
Faber TS; Zehender M; Just H
Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
[TBL] [Abstract][Full Text] [Related]
19. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
[TBL] [Abstract][Full Text] [Related]
20. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
Matiushin GV; Shul'man VA; Balog AI; Golovenkin SE; Bezruk AP; Ivanitskiĭ EA; Smirnova OV
Ter Arkh; 1998; 70(6):47-50. PubMed ID: 9695227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
